Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
CDKN2A (INK4a/ARF) is frequently disrupted in various types of human cancer, and germline mutations of this locus can confer susceptibility to melanoma and other tumours. However, because CDKN2A encodes two distinct cell cycle inhibitory proteins, p16INK4a and p14ARF (p19Arf in mice), the mechanism of tumour suppression by CDKN2A has remained controversial. Genetic disruption of Cdkn2a(p19Arf) (hereafter Arf) alone predisposes mice to tumorigenesis, demonstrating that Arf is a tumour-suppressor gene in mice. We mutated mice specifically in Cdkn2a(p16Ink4a) (hereafter Ink4a). Here we demonstrate that these mice, designated Ink4a*/*, do not show a significant predisposition to spontaneous tumour formation within 17 months. Embryo fibroblasts derived from them proliferate normally, are mortal, and are not transformed by oncogenic HRAS. The very mild phenotype of the Ink4a*/* mice implies that the very strong phenotypes of the original Ink4a/ArfDelta2,3 mice were primarily or solely due to loss of Arf. However, Ink4a*/Delta2,3 mice that are deficient for Ink4a and heterozygous for Arf spontaneously develop a wide spectrum of tumours, including melanoma. Treatment of these mice with the carcinogen 7,12-dimethylbenzanthracene (DMBA) results in an increased incidence of melanoma, with frequent metastases. Our results show that, in the mouse, Ink4a is a tumour-suppressor gene that, when lost, can recapitulate the tumour predisposition seen in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations in p16 , Rb , ARF and TP53 are frequently found in human cancers, and their tumour-suppressive roles have been confirmed in vivo using genetically modified mouse models [25 -29].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [28]
In the citing paper
“Mutations in p16 , Rb , ARF and TP53 are frequently found in human cancers, and their tumour-suppressive roles have been confirmed in vivo using genetically modified mouse models [25 -29].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [28]
In the citing paper
“For example, mouse embryonic fibroblasts (MEFs) lacking p53 [72] but not Ink4a (p16) or RB [73,74,75] escape Ras-induced senescence.”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [74]
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“MEFs mutated in components of the Rb1 or Trp53 pathways are defective in various aspects of proliferative control, displaying altered proliferation rates, cell-cycle distributions and cell size compared with wild-type cell”
BackgroundTodaro, G. J., & Green, H. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.2.299 · Cited by 2,736
Morgenstern, J. P., & Land, H. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3587 · Cited by 2,101
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585 · cited 1×
“No melanomas were observed in DMBA-treated control animals, either in those followed by us for 8 months or in historical control”
BackgroundTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Schwenk, F., Baron, U., & Rajewsky, K. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5080 · Cited by 1,289
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206 · cited 1×
“p16 INK4a and its downstream targets, the RB1 family members, have been implicated in this response in both huma”
BackgroundBmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF
Jacobs, J. J. L., Scheijen, B., Voncken, J.-W., Kieboom, K., Berns, A., & van Lohuizen, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2678 · Cited by 1,065
Self-citationThe p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911
Cited by
Items 501–567 of 567
Aspects of MEN1 Tumorigenesis in Endocrine Pancreas and Adrenal Glands
Chu, X. (2015) · DiVA (Digitala Vetenskapliga Arkivet)
Adam, N. M. (2006) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Epigenetic regulation of p16 Ink4a and Arf by JDP2 in cellular senescence
Nakade, K., Wasylyk, B., & Yokoyama, K. K. (2010) · BioMolecular Concepts · doi:10.1515/bmc.2010.008 · Cited by 1
Oncogene-Induced Senescence (OIS) as a Cellular Response to Oncogenic Stresses
Bourdeau, V., & Ferbeyre, G. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1075-2_3
Whitfield, J. (2001) · Nature · doi:10.1038/news010906-12
Mechanisms of KRAS-Mediated Pancreatic Tumor Formation and Progression: A Dissertation
Appleman, V. A. (2012) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/ekp2-9e89
Chemoprevention of Familial Melanoma
Hariharan, V. (2011) · Loyola eCommons (Loyola University of Chicago)
Epigenetic Control in Cellular Senescence
Helmbold, H., Deppert, W., & Bohn, W. (2011) · Wiley eBooks · doi:10.1002/9781118005743.ch3
A Short Thesis about Growth Factors in Gliomas
Hesselager, G. (2003) · Uppsala University Publications (Uppsala University)
Genetik des malignen Melanoms der Haut - Aktueller Wissensstand und klinische Anwendungen -
Weiss, J. M. (2002) · Aktuelle Dermatologie · doi:10.1055/s-2002-32052
Mechanisms that control the growth of cells in the presence of replication stress
Pascual, Á. M. (2013) · e_Buah
Polycomb Group of Genes and the Epigenetics of Aging
Mishra, K., & Mishra, R. K. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0639-7_8 · Cited by 1
p15Ink4b Loss Impairs the Maturation and Activation of Conventional Dendritic Cells
Fares, J. (2012) · DigitalGeorgetown (Georgetown University Library)
Langerhans Cells Facilitate Mutagenesis And Squamous Cell Carcinoma
Modi, B. G. (2012)
Greenwood, E. (2001) · Nature reviews. Cancer · doi:10.1038/35094033
Regulation of the G1-S transition by cyclin-dependent kinase inhibitors
Ramsey, M. R. (2007) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/sfvt-t742
Disruptive chemicals, senescence and immortality
Almagro, F., & Kyoto, S.-K. (2015)
NRIF is an essential component of apoptotic signaling by the p75 neurotrophin receptor
Linggi, M. S. (2005) · Europe PMC (PubMed Central)
Talluri, S. (2013) · Scholarship@Western (Western University)
In Vitro Modeling of Pancreatic Duct Cell Carcinogenesis
Leung, L. (2014) · TSpace (University of Toronto)
Genetic and Molecular Pathology of Melanoma
Piepkorn, M. W. (2004) · Springer eBooks · doi:10.1007/978-0-387-21619-5_3
Wi-, 基., 陈香美, Wi-, 细., Sa, 衰., 冯哲, & 傅博 (2007) · Science in China Series C-Life Sciences (in Chinese) · doi:10.1360/zc2007-37-1-15
Mouse models for brain tumor therapy
Charles, N. A., Lassman, A. B., & Holland, E. C. (2011) · Elsevier eBooks · doi:10.1016/b978-0-443-06967-3.00017-x
Bosenberg, M. (2004) · Wiley eBooks · doi:10.1002/0471675067.mmc009
Quelle, D. E., Nteeba, J., & Darbro, B. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.30060-8
Ramsey, M. R., Krishnamurthy, J., Pei, X., Torrice, C., Lin, W., Carrasco, D. R., Ligon, K. L., Xiong, Y., & Sharpless, N. E. (2023) · doi:10.1158/0008-5472.c.6495311
Ramsey, M. R., Krishnamurthy, J., Pei, X., Torrice, C., Lin, W., Carrasco, D. R., Ligon, K. L., Xiong, Y., & Sharpless, N. E. (2023) · doi:10.1158/0008-5472.c.6495311.v1
Baptista, B. R., Toigo, M., Justeau, G., Atmeh, P. A., Castro, T. D. F., Zysman, M., de Ménonville, C. T., Audureau, É., Schnyder, K., Wang, H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.05.674489 · Cited by 1
Senescence in Oncogenesis: From Molecular Mechanisms to Therapeutic Opportunities
Muñoz-Galván, S., & Carnero, A. (2014) · Springer eBooks · doi:10.1007/978-94-017-9421-3_7
Nilsson, L. M. (2007) · DiVA at Umeå University (Umeå University)
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25763070
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716396
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716393
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716360
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716357
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716378
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716414
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716384
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716363
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716411
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716402
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716390
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716372
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716405
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716408
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716366
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25762968
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716381
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716399
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716387
Filograna, A., Tito, S. D., Monte, M. L., Oliva, R., Bruzzese, F., Roca, M. S., Zannetti, A., Greco, A., Spano, D., Ayala, I., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26716375
Cudejko, C. (2010) · theses.fr (ABES) · doi:10.70675/3be56540zf3b1z4ee1z99ffz2dbbe7a0dc17
Roles of the multifunctional protein E4F1 in cellular senescence
Maciejewska, Z. (2010) · theses.fr (ABES) · doi:10.70675/21f99f8bze775z413fza364z48dd293ca460
p16INK4a, régulation du cycle cellulaire et microARN
Chien, W. W. (2009) · theses.fr (ABES) · doi:10.70675/dbb5386dzc679z454fzad91z9d53a61231ff
Modulation de la sénescence induite par les oncogènes par les glucocorticoïdes et rôle de EGR1
Carvalho, C. (2018) · theses.fr (ABES) · doi:10.70675/7cafc6a4za30dz467dz81a1z7033a7846a52
TP53INP1 et PLZF : acteurs du vieillissement dans l’hématopoïèse
Zidi, B. (2019) · theses.fr (ABES) · doi:10.70675/4db242d6zb664z4b84z9295z1ce4d24b024e
Suppressing p16INK4a promotes lung regeneration through a fibroblast lipogenic switch
Zysman, M. (2019) · theses.fr (ABES) · doi:10.70675/c507eaa0z188ez4332z952az2c54118917d6
Genetic and epigenetic modifiers of metastasis: Context matters
Welch, D. R., Swancutt, K. L., Walsh, R. M., & Fisette, G. (2026) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583526100201
Insights Into the Interplay Between the Senescent Cells and Immune Cells
Jaros, M., Schmidt, M., Neubert, L., Kamp, J. C., von Vietinghoff, S., Bräsen, J. H., Schmitt, R., & Melk, A. (2026) · Aging Cell · doi:10.1111/acel.70698
“These mice were originally described by Krimpenfort et al. (2001) and contain an allele resulting in loss of p16 Ink4a expression.”
Genomic correlates of metastatic competence and progression in human melanomaPreprint
Chatziioannou, E., Luthria, K. D., Shah, P., Armeanu–Ebinger, S., Admard, J., Schroeder, C., Forchhammer, S., Stihler, F., Zhang, X., Maiche, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.23.753695
“As loss of CDKN2A or activating CDK4 -mutations prime localized melanocytic tumours for metastatic progression into melanomas also in mice 29-31 , metastatic competence in melanoma is primed early by acquisition of distinct SCNAs and elaborated through continued copy-number evolution during…”
A cellular hierarchy in melanoma uncouples growth and metastatic phenotypes
梁瀚(Lianghan) (2023) · China National GeneBank DataBase · doi:10.26036/cnp0003961
The Senescent Cell Induced Bystander Effect
Wordsworth, J. (2014)
RB/E2F Regulation and Dual Activity in the Melanocytic System
Halaban, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-994-3_13
Knights, C. D., & Pestell, R. G. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-337-0_1
Metadata
- Authors
- Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A., & Berns, A.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Corresponding author
- Berns, Anton
- Venue
- Nature
- Published
- 2001-09
- Volume
- 413
- Issue
- 6851
- Pages
- 83-86
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003223749
- Cited by
- 568
- References
- 27
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 27 · 2023: 9 · 2022: 9 · 2021: 14 · 2020: 10 · 2019: 12 · 2018: 7 · 2017: 14 · 2016: 7 · 2015: 13 · 2014: 20 · 2013: 22 · 2012: 12
- FWCI
- 25.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Keywords
- p16INK4a, CDKN2A, p14ARF, metastatic melanoma, cancer susceptibility, tumor suppressor, germline mutations, melanoma predisposition, DMBA-induced carcinogenesis, embryonic fibroblasts, mouse model
- MeSH terms
- Animals, Carcinogens, Cell Transformation, Neoplastic, Cells, Cultured, Embryo, Mammalian, Female, Fibroblasts, Humans, Male, Melanoma, Experimental, Proteins, Genes, ras, 9,10-Dimethyl-1,2-benzanthracene, Gene Deletion, Point Mutation, Cyclin-Dependent Kinase Inhibitor p16, Genes, p16, Genetic Predisposition to Disease, Tumor Suppressor Protein p14ARF, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.